Neurotech reports strong trial results as firm raises A$10m to fund drug-registration activities by Steve Jones April 17, 2024April 18, 2024 Neurotech International (NTI) has raised a further A$10 million through new and existing institutional investors as […]
LGP hits cashflow-positive milestone after strong end to year by Steve Jones April 17, 2024April 17, 2024
Industry leaders urge medical bodies to ‘lean in’ to cannabis and not allow ‘bad actors’ to tarnish the medicine’s reputation by Martin Lane April 9, 2024April 10, 2024
Althea announces job cuts worth A$1.5m with more savings to come by Martin Lane March 28, 2024March 28, 2024
Local firms call for united voice to tackle import-export disparity as Australia is branded a cannabis ‘honeypot’ by Steve Jones March 27, 2024March 27, 2024
Cann Group eyes A$15m capital injection from New York-based investment firm by Martin Lane March 25, 2024March 27, 2024
A race to the bottom for flower prices as suppliers fail to ‘walk the walk’ on terpene profiles by Steve Jones March 25, 2024March 25, 2024